TSPYL2 and Alzheimer disease: Additionally, the percentage of TOX+ IL-4+ positive cells was significantly higher in CTCL than in AD (Figure 1F), and the expression of TOX was not restricted to CD4+ T cells in AD (Figures 1G, H), which is contrary to that in CTCL.